We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$849M
AUM Growth
+$64.3M
Cap. Flow
-$13.5M
Cap. Flow %
-1.59%
Top 10 Hldgs %
45.35%
Holding
87
New
28
Increased
23
Reduced
11
Closed
22

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$19.2M
2
INCY icon
Incyte
INCY
+$18.5M
3
ASRT
Assertio
ASRT
+$17.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$15.9M
5
CPB icon
Campbell Soup
CPB
+$15M

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$27.8M
2
SGI
Somnigroup International
SGI
+$20.7M
3
PRKS icon
United Parks & Resorts
PRKS
+$13.7M
4
GCI
Gannett Co., Inc
GCI
+$13.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.37%
2 Healthcare 32.65%
3 Consumer Discretionary 19.4%
4 Consumer Staples 9.7%
5 Industrials 3.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
26
DELISTED
Strongbridge Biopharma plc.
SBBP
$11.7M 1.38%
1,694,600
+2,600
+0.2% +$17.9K
SAM icon
27
Boston Beer
SAM
$1.74B
$10.9M 1.29%
+70,000
New +$10.2M
PCRX icon
28
Pacira BioSciences
PCRX
$1.05B
$10.8M 1.27%
+288,000
New +$11.6M
TPR icon
29
Tapestry
TPR
$24.4B
$10.5M 1.23%
+260,000
New +$11.5M
PII icon
30
Polaris
PII
$3.56B
$10.5M 1.23%
100,000
-116,000
-54% -$11M
HBI
31
DELISTED
Hanesbrands
HBI
$10.4M 1.23%
424,000
-176,000
-29% -$4.22M
IRBT
32
DELISTED
iRobot
IRBT
$10.2M 1.2%
+132,000
New +$12.1M
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.1M 1.19%
800,000
-20,000
-2% -$254K
ANF icon
34
Abercrombie & Fitch
ANF
$6.65B
$10.1M 1.19%
700,000
-200,000
-22% -$2.29M
MDGL icon
35
Madrigal Pharmaceuticals
MDGL
$12.5B
$9.54M 1.12%
212,000
-70,000
-25% -$1.31M
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$9.49M 1.12%
3,364,000
+964,000
+40% +$2.6M
BJRI icon
37
BJ's Restaurants
BJRI
$1.27B
$9.13M 1.08%
300,000
+192,000
+178% +$6.22M
ALIM
38
DELISTED
Alimera Sciences
ALIM
$8.46M 1%
417,600
+24,267
+6% +$519K
FTD
39
DELISTED
FTD Companies, Inc. Common Stock
FTD
$8.14M 0.96%
624,000
+96,000
+18% +$1.53M
TTSH
40
DELISTED
Tile Shop Holdings
TTSH
$8.03M 0.95%
+632,000
New +$9.88M
ZGNX
41
PUT
DELISTED
Zogenix, Inc.
ZGNX
$7.01M 0.83%
+200,000
New +$2.71M
ETSY icon
42
Etsy
ETSY
$7.02B
$6.75M 0.8%
+400,000
New +$6.31M
PRKS icon
43
CALL
United Parks & Resorts
PRKS
$1.83B
$6.5M 0.77%
+500,000
New +$6.84M
PAG icon
44
Penske Automotive Group
PAG
$14.4B
$5.9M 0.69%
+124,000
New +$5.36M
BETR
45
DELISTED
Amplify Snack Brands, Inc.
BETR
$5.79M 0.68%
+816,000
New +$6.71M
NTRI
46
DELISTED
NutriSystem, Inc.
NTRI
$5.59M 0.66%
100,000
– –
BLUE
47
DELISTED
bluebird bio
BLUE
$5.22M 0.61%
2,934
+772
+36% +$1.08M
ENTA icon
48
Enanta Pharmaceuticals
ENTA
$410M
$5.05M 0.6%
108,000
-156,000
-59% -$6.27M
ACHN
49
DELISTED
Achillion Pharmaceuticals
ACHN
$4.58M 0.54%
+1,020,000
New +$4.53M
SFM icon
50
Sprouts Farmers Market
SFM
$7.59B
$4.43M 0.52%
+236,000
New +$5.22M
1
2
3 4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Armistice Capital held 87 positions worth $849M, up 8.2% from $785M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital's Q3 2017 filing shows 28 new, 23 increased, 11 reduced and 22 closed positions. Its largest new stake was United Therapeutics: 150,000 shares worth $17.6M. The largest sale was Hain Celestial, an estimated $27.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Armistice Capital's largest Q3 2017 buy was United Therapeutics: 150,000 shares worth $17.6M.
  • Armistice Capital added most to Assertio in Q3 2017, an estimated $17.4M increase.
  • Armistice Capital's biggest Q3 2017 reduction was Momenta Pharmaceuticals, Inc., cutting an estimated $11.5M.
  • Armistice Capital fully exited Hain Celestial in Q3 2017, selling an estimated $27.8M.
  • Armistice Capital's ten largest holdings make up 45% of its $849M portfolio in Q3 2017.
  • Armistice Capital opened 28 new positions and closed 22 in Q3 2017.
  • Armistice Capital's portfolio value rose 8.2% quarter-over-quarter to $849M.

Based on Armistice Capital's 13F filing for Q3 2017, filed 14 Nov 2017.